MTMI Hybrid Breast Biopsy Course
Stereotactic and Ultrasound-Guided Breast Biopsy
June 7-8, 2024 • Cincinnati, OH
Top WorkPlace 2024
Thank you to our employees for making Mammotome a great place to work!
Sentimag® Localization Platform
The all-in-one localization platform for physicians and patients who demand a better standard of care.
HydroMARK™ Plus Marker
Same great benefits of the original HydroMARK™ markers, with added features to alleviate displacement, enhance visibility, and ease of locating.1,2,3
Products & Solutions
At Mammotome, we are committed to providing best-in-class technology to help clinicians accurately diagnose breast cancer. Never forgetting that at the heart of each breast cancer diagnosis is the patient. Our product portfolio covers two integrated main steps in the overall breast cancer treatment pathway: breast biopsy and local surgical treatments.
Neoprobe® Gamma Detection System
Neoprobe® GDS offers exceptional accuracy, effortless operation and advanced clinical capability.
Sentimag® Localization Platform
Four techniques in one platform allow for more surgical options than any other non-gamma localization system.
Mammotome® Markers
Mammotome® Markers offer clinicians the most comprehensive portfolio available, providing a customized solution for every breast biopsy need.
Mammotome® Elite System
The Mammotome® Elite breast biopsy device combines vacuum-assisted biopsy tissue quality with the ease and speed of a spring-loaded core needle.
Mammotome DualCore™ System
The Mammotome DualCore™ system is lightweight, precise, and reliable, offering a spring-loaded action for quality sampling capability.
Mammotome Service and Support
Service and support from the team that knows your Mammotome products best.
Mammotome Revolve™ System
Redefining procedural efficiency without compromising tissue quality – from positioning to diagnosis.
Mammotome Confirm™ SRS
Veryify the presence of microcalcifications during stereotactic biopsies quickly and easily.
XPERT® 40 SRS
When you need to identify fine details, in a wide range of specimens, in a short amount of time.
1. HydroMARK™ Device Test – PCR-000414, Summative Usability
2. HydroMARK™ Design Plan – ADD-00013 Rev G, Page 15
3. HydroMARK™ Device Test – PCR-000299, SDR0098 Vacuum Suction Testing
Upcoming Events & Initiatives
Mammotome Launches the LumiMARK™ Biopsy Site Marker
This marker portfolio is distinct from every angle, designed with visibility top of mind.
Growing and Connecting Talent Through Associate Led Groups
Explore how our Associate Led Groups (ALG) provide an internal network for women at Mammotome to help elevate their careers.
About Us
At Mammotome, we are a global team dedicated to advancing breast care. Our passion is driving innovative technologies that create efficiencies for clinicians, while never forgetting that at the heart of every breast cancer journey is a patient.
Learn how we transformed the future of breast cancer diagnostics and continue to discover new opportunities to deliver better solutions and care.
850+
Dedicated
Associates
9
Global
Locations
65
Countries
Where Our Products Are Sold
Join the Team
Mammotome associates know that every moment matters when it comes to advancing breast cancer diagnostics and surgical solutions. We’re a global team of engineers, designers, communicators, strategists and specialists focused on improving patient outcomes. Inspired to grow every day, our collaborative, diverse, high-performing team is a trusted leader in the breast care industry. And as part of Danaher, we’re growing fast and innovating faster.
